{"nct_id":"NCT02760602","title":"A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease","status":"TERMINATED","status_verified_date":"2019-09","start_date":"2016-06","start_date_type":null,"primary_completion_date":"2017-05","primary_completion_date_type":"ACTUAL","completion_date":"2017-05","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["LLY"]}